InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Grant Sean, 首席财务官. Insider active across 1 company, notably Vera Therapeutics, Inc.. Aggregated, 11 filings have been logged. Split: 4 buys · 1 sell. Total volume traded: €468k. History available since 15 June 2022. The latest transaction was filed on 23 February 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Sean Grant serves as Chief Financial Officer at Vera Therapeutics, Inc. In this role, he oversees the company's financial management, including financial planning, risk management, and regulatory compliance. Sean plays a key role in optimizing financial resources and in strategic decision-making to support the company's growth.